.Attributes Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint calls for inclusion of people along with MASLD and also dimension of liver end results in cardio-- renal-- metabolic tests, when data propose mechanistically conceivable perks as well as clinical security-- as well as details considerations for test style as well as regulatory approval.